Physician profile
Brian A Cost
NPI 1699988048
$4,355.94
in general payments reported to CMS, 2019-2025
37 companies · $734 in 2025
The $734 reported for 2025 was more than what 87% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $144 · 2021: $564 · 2022: $648 · 2023: $977 · 2024: $1,117 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,828.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $970.23 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $748.09 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $517.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $235.85 | 2019-2025 | |
| Corium, LLC | $228.90 | 2023-2024 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.44 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $124.88 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.99 | 2023-2024 | |
| Abbott Laboratories | $122.31 | 2021-2024 | Proclaim, Freestyle Libre 2, Freestyle Libre 3 |
| Exact Sciences Corporation | $121.55 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $116.12 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Allergan, INC. | $89.88 | 2019-2020 | |
| Genentech USA, INC. | $81.08 | 2019-2024 | Xofluza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.25 | 2022-2023 | Glyxambi, Trijardy Xr, Tradjenta |
| Merck Sharp & Dohme LLC | $69.29 | 2021-2025 | Capvaxive, Gardasil 9 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.